Literature DB >> 26658132

Effects of in vitro fertilization and maternal characteristics on perinatal outcomes: a population-based study using siblings.

Jorien Seggers1, Martina Pontesilli2, Anita C J Ravelli3, Rebecca C Painter4, Mijna Hadders-Algra5, Maas Jan Heineman4, Sjoerd Repping6, Ben Willem J Mol7, Tessa J Roseboom8, Sabine Ensing9.   

Abstract

OBJECTIVE: To study birthweight in consecutively born sibling singletons conceived with and without in vitro fertilization (IVF) to disentangle the effects of maternal characteristics from those of the IVF treatment itself.
DESIGN: Population-based study.
SETTING: Not applicable. PATIENT(S): Firstborn and secondborn children from a 9-year birth cohort (1999-2007) comprising of 272,551 women who conceived two siblings. INTERVENTION(S): No intervention; children were conceived naturally or through IVF. MAIN OUTCOME MEASURE(S): Birthweight. RESULT(S): The study included 545,102 children born by natural conception (NC) or IVF with the data set obtained from the population-based Netherlands Perinatal Registry (PRN) containing information on pregnancies, deliveries, and neonatal outcomes. We used two approaches: [1] the intersibling approach and [2] the sibling-ship approach. In the first approach we included children born to four groups of mothers who conceived in the following order (numbers indicate birth order): NC1-NC2 (reference, n = 254,721), IVF1-NC2 (n = 1342), NC1-IVF2 (n = 471), and IVF1-IVF2 (n = 687). Several comparisons were made to interpret the effects of IVF and maternal characteristics separately. In the second approach, perinatal outcomes of IVF children (n = 1,813) were compared with those of their NC siblings (n = 1,813). The intersibling analyses suggested an association between maternal characteristics and a lower birthweight, with estimates of the maternal effect ranging from -7 g (95% CI, -40; 26) to -101 g (95% CI, -170; -32). Neither the intersibling analyses nor the sibling-ship analyses indicated an additional adverse effect of IVF treatment itself. CONCLUSION(S): Maternal characteristics of subfertile women are associated with a lower birthweight. In vitro fertilization treatment itself does not additionally contribute to a lower birthweight in the offspring.
Copyright © 2016 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Assisted reproductive technology; in vitro fertilization; perinatal outcomes; siblings; subfertility

Mesh:

Year:  2015        PMID: 26658132     DOI: 10.1016/j.fertnstert.2015.11.015

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  15 in total

1.  Fresh and Frozen-Thawed Embryo Transfer Compared to Natural Conception: Differences in Perinatal Outcome.

Authors:  Suzanne Spijkers; Jan Willem Lens; Roel Schats; Cornelis B Lambalk
Journal:  Gynecol Obstet Invest       Date:  2017-05-13       Impact factor: 2.031

Review 2.  In Vitro fertilization and adverse obstetric and perinatal outcomes.

Authors:  Chantae S Sullivan-Pyke; Suneeta Senapati; Monica A Mainigi; Kurt T Barnhart
Journal:  Semin Perinatol       Date:  2017-08-14       Impact factor: 3.300

3.  Increased risk of large-for-gestational age birthweight in singleton siblings conceived with in vitro fertilization in frozen versus fresh cycles.

Authors:  Barbara Luke; Morton B Brown; Ethan Wantman; Judy E Stern; James P Toner; Charles C Coddington
Journal:  J Assist Reprod Genet       Date:  2016-12-01       Impact factor: 3.412

4.  Obstetric and perinatal complications associated with assisted reproductive treatment in Spain.

Authors:  Ana Ballesta-Castillejos; Juan Gomez-Salgado; Julian Rodriguez-Almagro; Inmaculada Ortiz-Esquinas; Antonio Hernández-Martínez
Journal:  J Assist Reprod Genet       Date:  2019-11-18       Impact factor: 3.412

5.  Exposure to non-persistent chemicals in consumer products and fecundability: a systematic review.

Authors:  Alison E Hipwell; Linda G Kahn; Pam Factor-Litvak; Christina A Porucznik; Eva L Siegel; Raina N Fichorova; Richard F Hamman; Michele Klein-Fedyshin; Kim G Harley
Journal:  Hum Reprod Update       Date:  2019-01-01       Impact factor: 15.610

6.  Effect of parental and ART treatment characteristics on perinatal outcomes.

Authors:  M Pontesilli; M H Hof; A C J Ravelli; A J van Altena; A T Soufan; B W Mol; E H Kostelijk; E Slappendel; D Consten; A E P Cantineau; L A J van der Westerlaken; W van Inzen; J C M Dumoulin; L Ramos; E B Baart; F J M Broekmans; P M Rijnders; M H J M Curfs; S Mastenbroek; S Repping; T J Roseboom; R C Painter
Journal:  Hum Reprod       Date:  2021-05-17       Impact factor: 6.918

Review 7.  Risk of adverse pregnancy and perinatal outcomes after high technology infertility treatment: a comprehensive systematic review.

Authors:  Stefano Palomba; Roy Homburg; Susanna Santagni; Giovanni Battista La Sala; Raoul Orvieto
Journal:  Reprod Biol Endocrinol       Date:  2016-11-04       Impact factor: 5.211

8.  Maternal and Live-birth Outcomes of Pregnancies following Assisted Reproductive Technology: A Retrospective Cohort Study.

Authors:  Linling Zhu; Yu Zhang; Yifeng Liu; Runjv Zhang; Yiqing Wu; Yun Huang; Feng Liu; Meigen Li; Saijun Sun; Lanfeng Xing; Yimin Zhu; Yiyi Chen; Li Xu; Liangbi Zhou; Hefeng Huang; Dan Zhang
Journal:  Sci Rep       Date:  2016-10-20       Impact factor: 4.379

9.  Pregnant after assisted reproduction: a risk pregnancy is born! 18-years perinatal outcome results from a population-based registry in Flanders, Belgium.

Authors:  W Ombelet; G Martens; L Bruckers
Journal:  Facts Views Vis Obgyn       Date:  2016-12

10.  Separating parental and treatment contributions to perinatal health after fresh and frozen embryo transfer in assisted reproduction: A cohort study with within-sibship analysis.

Authors:  Kjersti Westvik-Johari; Liv Bente Romundstad; Deborah A Lawlor; Christina Bergh; Mika Gissler; Anna-Karina A Henningsen; Siri E Håberg; Ulla-Britt Wennerholm; Aila Tiitinen; Anja Pinborg; Signe Opdahl
Journal:  PLoS Med       Date:  2021-06-25       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.